Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Vimpat
(lacosamide)
Uses, side effects, dosage information & price range
About this medicine
Vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
Common Brand Names for this Composition
The following popular commercial brand names contain lacosamide as their active ingredient composition:
Vimpat
UCB Pharma SA
Lacosamide Adroiq
Extrovis EU Ltd
Lacosamide Accord
Accord Healthcare S.L.U.
Lacosamide UCB
UCB Pharma S.A.
Lacosamide Pain UCB Pharma
UCB Pharma S.A.
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
lacosamide
Category
Antiepileptics
Manufacturer
UCB Pharma SA
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.